Haematosalpinx/Haematoma of broad ligament

N14_MAEMABROAD

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N83.6, N83.7 Hospital discharge: ICD-9 — 6207 Cause of death: ICD-10 — N83.6, N83.7 Cause of death: ICD-9 — 6207 2 out of 7 registries used, show all original rules.	71
4. Check minimum number of events None	71
5. Include endpoints None	71
6. Filter based on genotype QC (FinnGen only)	71

Control definitions (FinnGen only)

Control exclude: N14_FEMALEGENNONINF

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	N14_MAEMABROAD
CONTROL_EXCLUDE	N14_FEMALEGENNONINF
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N836\|N837
HD_ICD_9	6207
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N836\|N837
COD_ICD_9	6207
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Haematosalpinx/Haematoma of broad ligament based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	390	390	-
Only index persons	377	377	-
Unadjusted period prevalence (%)
Whole population	0.01	0.01	-
Only index persons	0.01	0.01	-
Median age at first event (years)
Whole population	-	39.54	-
Only index persons	-	39.34	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	71	71	-
Unadjusted period prevalence (%)	0.02	0.02	-
Median age at first event (years)	37.87	37.87	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
66: Matched controls
659

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N83.6

ICD-10 Finland

Haematosalpinx

+∞

52.1

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

94.9

26.6

N83.7

ICD-10 Finland

Haematoma of broad ligament

+∞

19.8

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

+∞

14.0

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

21.6

13.1

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

7.0

11.8

102

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

6.7

11.1

JAH01

NOMESCO Finland

Laparoscopy

17.6

8.6

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

10.0

8.5

N80.1

ICD-10 Finland

Endometriosis of ovary

+∞

8.5

N81.6

ICD-10 Finland

Rectocele

51.3

7.9

N83.1

ICD-10 Finland

Corpus luteum cyst

+∞

7.4

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

23.1

7.4

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

4.1

6.9

148

N73.6

ICD-10 Finland

Female pelvic peritoneal adhesions

+∞

6.3

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

10.66

9.22

2.7

1.4

53.2

102.6

pmol/l

0.46

(3037467) Urinalysis macro (dipstick) panel - Urine

345

3.95

5.68

4.6

3.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4.16

3.80

1.1

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

100

2.74

3.45

1.9

0.4

0.7

mg/l

1.20

(3019150) Specific gravity of Urine by Refractometry

110

2.61

3.25

5.8

3.2

1.0

kg/l

—

(3026008) Bacteria identified in Urine by Culture

140

2.50

3.23

2.6

2.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

3.09

2.90

1.5

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

166

2.26

2.71

2.8

3.4

24.3

28.3

u/l

0.62

161

(3031040) Bacteria [#/volume] in Urine by Automated count

330

2.26

2.63

5.2

3.5

—

(40768804) Tissue Pathology biopsy report

210

2.19

2.63

2.3

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

4.73

2.54

1.3

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

239

2.14

2.53

3.7

3.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.71

2.48

1.4

1.8

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

6.62

2.41

1.0

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

6.62

2.41

4.2

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

110

2.29

2.38

1.3

2.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

184

2.09

2.30

4.9

3.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

5.88

2.25

1.4

2.3

12.3

13.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

247

2.04

2.24

3.4

6.2

8.8

9.1

umol/l

0.07

237

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

5.28

2.10

1.6

1.0

—

(3019060) Gas panel - Arterial blood

3.58

2.02

6.1

4.7

—

(3042936) Bacteria identified in Isolate by Culture

2.34

1.98

1.5

1.9

—

(3015736) pH of Urine

193

1.96

4.7

2.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

135

2.04

1.93

1.6

1.3

—

(40768797) Stomach Pathology biopsy report

2.52

1.93

1.3

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

144

2.01

1.90

1.3

2.0

—

(4010399)

3.26

1.85

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

4.05

1.74

1.0

2.8

—

(3002256) Pathology report gross observation

2.47

1.74

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2.87

1.62

5.9

5.8

0.7

0.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2.87

1.62

5.9

5.8

1.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2.76

1.56

5.9

5.6

95.8

95.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

3.50

1.55

1.0

1.9

—

4.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

3.50

1.55

1.2

1.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2.42

1.54

1.4

2.3

2.8

4.1

umol/l

—

(3023511) Choriogonadotropin [Units/volume] in Urine

3.02

1.54

1.3

1.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3.02

1.54

6.8

4.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2.32

1.54

1.6

1.3

87.3

122.5

iu/ml

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

146

1.85

1.51

1.7

3.2

10.9

18.2

ng/l

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.49

1.49

1.6

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.49

1.49

1.6

—

(3022621) pH of Urine by Test strip

2.66

1.49

2.3

1.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

110

1.85

1.31

3.8

3.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2.91

1.30

4.8

5.9

25.1

24.0

mmol/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

0.00

1.19

0.0

2.8

—

2.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.91

1.19

1.9

2.1

—

(3023368) Bacteria identified in Blood by Culture

1.84

1.19

2.7

3.6

—

(1002224) Polysomnography panel

2.61

1.17

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2.48

1.16

1.7

2.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1.86

1.11

3.7

2.8

68.8

87.0

ng/l

—

(3032080) INR in Blood by Coagulation assay

159

1.66

1.10

5.6

5.0

1.2

1.1

inr

—

(40761535) Cells panel - Urine sediment

1.97

0.91

4.3

3.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.71

0.89

2.2

2.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.87

0.88

1.3

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.87

0.88

2.4

3.0

4.5

pmol/l

—

(3013707) Erythrocyte sedimentation rate by Westergren method

412

1.51

0.82

4.9

3.6

9.9

10.0

mm/h

0.03

384

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

179

1.51

0.82

1.8

1.7

99.2

93.3

pmol/l

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.81

0.0

3.1

—

22.1

—

(1761868) Lipid panel - Serum or Plasma

233

0.64

0.79

1.4

2.4

—

(36660697) Celiac disease serology panel - Serum

1.67

0.64

1.1

—

(3000492) Spirometry study

1.64

0.63

1.9

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.61

0.0

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

0.00

0.61

0.0

2.1

—

43.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

0.00

0.61

0.0

2.0

—

24.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

125

1.47

0.61

4.8

2.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

0.00

0.60

0.0

2.0

—

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

126

1.46

0.59

1.7

2.0

122.5

175.3

u/l

0.37

119

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.52

0.56

4.7

3.3

27.8

33.0

—

(4035726)

1.59

0.54

1.2

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1.55

0.53

3.0

4.0

218.2

235.0

u/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

129

1.42

0.52

1.6

1.7

—

(3013512) EKG study

120

1.43

0.52

2.3

2.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

0.57

0.49

1.8

1.4

430.0

102817336.3

pmol/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

583

1.50

0.49

15.2

9.3

29.9

19.7

mg/l

1.14

415

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

538

1.43

0.48

10.5

8.6

88.5

86.8

ml/min/173m2

0.27

421

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.48

0.44

1.5

1.8

—

(42870588) Differential panel, method unspecified - Blood

161

1.34

0.43

3.7

4.7

—

(3019225) pH of Specimen

1.51

0.41

3.0

4.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.51

0.41

2.0

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.40

0.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.46

0.40

1.4

1.7

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

0.00

0.39

0.0

2.0

—

0.6

—

(3025941) Bacteria identified in Stool by Culture

1.51

0.37

1.0

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

137

1.32

0.36

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.43

0.36

1.7

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

156

1.30

0.36

1.7

1.8

—

(40761511) CBC panel - Blood by Automated count

625

1.47

0.35

12.1

8.9

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.33

0.34

2.0

2.4

20.0

21.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.33

0.29

1.8

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.24

0.28

1.4

1.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

565

1.26

0.24

14.2

10.0

139.6

139.9

mmol/l

0.31

548

(3018095) Leukocytes [#/volume] in Urine

145

1.23

0.23

3.1

2.7

8.8

93.4

e6/l

1.64

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.30

0.23

1.2

1.7

—

(3044889) 12 lead EKG panel

352

1.17

0.21

3.6

2.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

0.21

0.0

2.1

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.21

0.0

1.7

—

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.21

0.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1.22

0.20

1.7

1.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

138

1.21

0.19

4.1

2.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

568

1.23

0.19

14.1

9.9

3.9

mmol/l

0.00

550

(3020682) Albumin/Creatinine [Ratio] in Urine

119

1.22

0.19

3.7

3.9

1.4

15.2

mg/mmol

—

(3000494) Fungus identified in Specimen by Culture

1.16

0.18

1.0

1.3

—

(3012516) Albumin [Mass/volume] in Urine

111

1.21

0.17

3.2

3.1

11.2

735.2

mg/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.16

0.17

1.8

1.6

—

(21494755) Public health laboratory ask at order entry panel

0.77

0.15

1.1

1.4

—

(3003694) ABO and Rh group [Type] in Blood

168

0.86

0.13

1.5

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.17

0.10

1.2

—

(3022145) Colonoscopy Study observation

1.08

0.09

1.2

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

637

1.24

0.08

9.2

8.3

21.8

24.4

u/l

1.02

614

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

456

1.09

0.08

3.4

3.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.86

0.07

1.6

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.89

0.07

2.3

2.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

579

1.11

0.06

4.0

3.5

1.5

1.6

mmol/l

1.04

546

(36304419) Bacteria [Presence] in Urine

110

1.11

0.05

3.4

2.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

570

0.92

0.05

13.7

10.8

40.1

39.6

0.43

456

(40760892) CBC W Ordered Manual Differential panel - Blood

135

0.95

0.00

2.2

4.9

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

119.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.0

2.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

174.7

—

(3049717) Cytology report of Urine Cyto stain

0.00

0.0

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

0.91

0.00

1.4

1.8

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

1.4

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

7.6

—

2193.7

—

(4027681)

0.00

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

6.1

—

1078.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

19.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.0

1.2

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.0

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

0.00

0.0

1.6

—

13.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

2.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.96

0.00

8.0

5.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

0.00

0.0

1.0

—

653.6

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.0

1.8

—

9.4

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.0

—

95.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

0.0

1.4

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

0.00

0.0

1.0

—

3.8

—

(4306422)

0.00

0.0

1.0

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

0.00

0.0

1.0

—

5.8

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

0.00

0.0

1.0

—

0.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

0.0

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

0.00

0.0

1.0

—

0.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

1.3

—

105.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.0

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

1.3

—

4.1

—

(3024928) Oxygen saturation in Venous blood

0.00

0.0

2.0

—

(4062490)

0.00

0.0

1.0

—

(40758558) Short blood count panel - Blood

140

1.00

0.00

5.1

7.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_MAEMABROAD and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_MAEMABROAD.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: N14_MAEMABROAD – Haematosalpinx/Haematoma of broad ligament

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Haematosalpinx/Haematoma of broad ligament

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints